111 Inc
NASDAQ:YI
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
CN |
111 Inc
NASDAQ:YI
|
111.3m USD | -1.8 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
74.7B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.9B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.4B USD | 150.7 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
47.7B BRL | 26.7 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
977.6B JPY | 15.4 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
46.6B CNY | 11.2 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
84.8B MXN | 11.8 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.4B SAR | 12.7 | ||
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
554.4B JPY | 10.2 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.6B CNY | 7 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.